Loading company…
Vbiosci develops animal vaccines, biological drugs, and related technologies and products.
Founded in 2016 and based in Beijing, China, Vbiosci develops animal vaccines and biological drugs, with research platforms spanning vaccine technology, antibody drugs, and cell growth. Its pipeline covers poultry, livestock, and pets, and it also sells pet food products. In April 2026, it raised venture funding from Efung Capital to support R&D, capacity expansion, and market development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in